OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

AES CORP. DL-,01/  US00130H1059  /

München
05/07/2024  10:26:24 Chg. +0.550 Volume Bid21:59:58 Ask21:59:58 Market Capitalization Dividend Y. P/E Ratio
17.012EUR +3.34% 125
Turnover: 2,126.500		 -Bid Size: - -Ask Size: - 11.61 bill.EUR - -
GlobeNewswire 01/07 Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...
GlobeNewswire 27/06 Brand Trust Is Higher for Utilities That Spend More on Communication and Highlight Savings and Envir...
GlobeNewswire 27/06 Inmagene Announces Positive Topline Results of a Multiple Ascending Dose (MAD) Study of IMG-004, a N...
GlobeNewswire 27/06 Lantronix Launches New EDS5000 Series Device Server
GlobeNewswire 26/06 AMERICAN SALARS SUBMITS SAMPLES FOR ASSAY FROM THE NEVADA BLACK ROCK SOUTH LITHIUM BRINE PROJECT
GlobeNewswire 25/06 Exploration Drilling at Becher Project Recommences
GlobeNewswire 25/06 Tsecond and Carahsoft Partner to Bring Low SWaP, High-Performance Data Solutions for AI, Analytics a...
GlobeNewswire 25/06 Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Tri...
GlobeNewswire 24/06 InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel ...
GlobeNewswire 21/06 Neon Bloom Completes Acquisition of Advanced Executive Sales, LLC
GlobeNewswire 20/06 Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose ...
GlobeNewswire 20/06 Aphaia Pharma Announces Positive Results from Phase 2 Trial Evaluating its Lead Drug Formulation for...
GlobeNewswire 20/06 Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potentia...
GlobeNewswire 18/06 XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treat...
GlobeNewswire 18/06 Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low ...
GlobeNewswire 17/06 2024 CSO Award Winners and Hall of Fame Inductees to be Recognized at the CSO Conference & Awards
GlobeNewswire 17/06 FDA Approves Phase II Clinical Trial for Ruxoprubart in ANCA Associated Vasculitis (AAV) – a Chronic...
GlobeNewswire 14/06 Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Associatio...
GlobeNewswire 14/06 Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Tria...
GlobeNewswire 13/06 Lantronix Wins 2024 IoT Evolution Asset Tracking Award for FOX3 Telematic Gateway
GlobeNewswire 12/06 NKGen Biotech Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at ...
GlobeNewswire 12/06 Hickcoin Exchange Releases Latest Security Report, Demonstrating Robust Protection Capabilities
GlobeNewswire 12/06 NodThera’s NLRP3 Inhibitor NT-0796 Meets Primary Endpoint of Inflammation Reversal in Phase Ib/IIa T...
GlobeNewswire 12/06 AMERICAN SALARS COMPLETES PHASE 1 EXPLORATION OF BLACK ROCK SOUTH LITHIUM BRINE PROJECT, NV
GlobeNewswire 10/06 Panbela Announces Oral Presentation at Digestive Disease Week (DDW):